Insider · CIK 0001783056
Lisa Lynn Decker
Files at CMRX (CHIMERIX INC), IGMS (IGM Biosciences, Inc.). First filing Dec 18, 2024, latest Jul 25, 2025.
In brief
Lisa Lynn Decker files SEC Form 4 as officer and director at IGMS (IGM Biosciences, Inc.), and also at CMRX (CHIMERIX INC). Since Dec 18, 2024, Lisa Lynn Decker has reported 0 open-market buys worth $0 and 4 open-market sells worth $20k, the latest filed on Jul 25, 2025.
A track record needs three past buys with six months of prices behind them; Lisa Lynn Decker has 0, so none is measured yet.
The newest scored trade: sold $5,612 of IGMS on Jul 23, 2025, filed Jul 25, 2025, scored 30 (weak).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | IGM Biosciences, Inc. | $5,612 4,409 shares | -6% | - | |
| 30Weak | IGM Biosciences, Inc. | $1,140 951 shares | -1% | - | |
| 30Weak | IGM Biosciences, Inc. | $5,550 4,512 shares | -6% | - | |
| 30Weak | IGM Biosciences, Inc. | $7,951 1,063 shares | -1% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 14, 2025 | IGMS IGM BIOSCIENCES, INC. | 5,079 0.01% of outstanding | $6,552 | Mar 14, 2025 | $7,951 |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 23, 2025 | IGMS IGM Biosciences, Inc. | SOpen-market sale Common Stock | -4,409 | $1.27 | $5,612 | 68,169 | Jul 25, 2025 |
| Jun 16, 2025 | IGMS IGM Biosciences, Inc. | SOpen-market sale Common Stock | -951 | $1.20 | $1,140 | 72,578 | Jun 20, 2025 |
| Apr 21, 2025 | CMRX CHIMERIX INC | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -100,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | CMRX CHIMERIX INC | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -60,000 | - | - | 0 | Apr 21, 2025 |
| Mar 14, 2025 | IGMS IGM Biosciences, Inc. | SOpen-market sale Common Stock | -4,512 | $1.23 | $5,550 | 73,529 | Mar 18, 2025 |
| Dec 16, 2024 | IGMS IGM Biosciences, Inc. | SOpen-market sale Common Stock | -1,063 | $7.48 | $7,951 | 78,041 | Dec 18, 2024 |
Questions about Lisa Lynn Decker
Answered from the filings on this page, as of the latest one.
Is Lisa Lynn Decker buying or selling?
Not in the last 12 months. Lisa Lynn Decker's latest open-market trade on SEC Form 4 was sold $5,612 of IGMS on Jul 23, 2025.
How did Lisa Lynn Decker's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Lisa Lynn Decker has 0.
Where does Lisa Lynn Decker file Form 4?
Lisa Lynn Decker has filed Form 4 at IGMS (IGM Biosciences, Inc.) as CHIEF BUSINESS OFFICER; CMRX (CHIMERIX INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.